Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.

Subgroup analyses showed that patients treated with platinum-based agents and taxanes had the highest prevalence of chronic ...

Chemotherapy has been known to cause damage to peripheral nerves, and sometimes the pain is chronic and severe enough that chemotherapy doses are reduced or discontinued. But prior research has not ...

Chemotherapy-induced peripheral neuropathy (CIPN) is a common and often debilitating side effect of cancer treatment, particularly associated with certain chemotherapeutic agents like taxanes and ...

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 ...

BC, CNM, RNFA, spoke about the oncology nurse’s and APP’s roles in managing chemotherapy-induced peripheral neuropathy in ...

The American Academy of Family Physicians recommends that peripheral neuropathy treatment address the underlying disease process, correct nutritional deficiencies, and aim to provide relief from ...

The compound was discovered and initially developed by Stony Brook University’s Iwao Ojima, PhD, and Martin Kaczocha, PhD.

Amiodarone. This drug, used for arrhythmias, may cause peripheral neuropathy. Chemotherapy drugs. Some chemo drugs have been shown to cause peripheral neuropathy. Certain antibiotics. Several ...

“Peripheral neuropathy is a degenerative disease, meaning it just keeps getting worse over time. We often associate it with diabetes, but there’s also chemotherapy-induced peripheral ...

For many cancer patients, pain, fatigue, neuropathy and nausea can be part of the treatment process as their bodies react to ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...